Luminescence of favipiravir in skin appendages and sclera. A controlled study and literature review
Photodermatology, Photoimmunology & Photomedicine · 2024
DOI: 10.1111/phpp.12919 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Photodermatology, Photoimmunology & Photomedicine, 2024. Verfasst von Deniz Demircioğlu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Acıbadem Mehmet Ali Aydınlar University School of Medicine, Istanbul, Turkey. Hauptthemen laut MEDLINE: Luminescence, COVID-19, Amides, Pyrazines. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
Background/Objectives Favipiravir is an antiviral agent, recently used for COVID‐19 infections. Several reports associate favipiravir intake with Wood's lamp fluorescence of hair, nails, and sclera. The present study was designed to elucidate the positivity rates, and sites of favipiravir‐related fluorescence and to unravel the site‐specific changes in fluorescence positivity rates by a function of time past exposure.
Methods
The study population comprised 50 patients and 50 control individuals. All patients in the patient group had received a full dose of favipiravir for COVID‐19 infection. Fifty volunteers served as the control group. Wood's lamp examination was performed in a completely darkened room, and the positivity rate, extent, pattern, and distribution of fluorescence were recorded.
Results
Wood's light revealed fluorescence of the fingernails, toenails, sclera, and hair in 35 (70%), 35 (70%), 22 (44%), and 8 (16%) patients, respectively. No control individual tested positive by Wood's lamp. Statistical analysis revealed significant differences between patient and control groups in terms of Wood's light luminescence in the fingernails ( p = .000), toenails ( p = .000), sclera ( p = .000) and hair ( p = .003). Although fingernail, toenail, and hair fluorescence positivity rates declined or ceased at or after 91 days of favipiravir exposure, ocular fluorescence positivity rates were prolonged up to 188 days.
Conclusions
These findings confirm that favipiravir may produce fluorescence of nails, sclera, and hair, detectable by Wood's light starting from the initial month and peaking at second‐ and third months following exposure to the medication. Although nail and hair fluorescence tend to abate after 3 months, ocular fluorescence may persist even longer than 6 months after cessation of the medication.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Acıbadem Mehmet Ali Aydınlar University School of Medicine, Istanbul, Turkey.
ORCID-Profile: Deniz Demircioğlu, Emel Öztürk Durmaz
Zitieren
APA
Demircioğlu, D., & Durmaz, E. Ö. (2024). Luminescence of favipiravir in skin appendages and sclera. A controlled study and literature review. Photodermatology, Photoimmunology & Photomedicine. https://doi.org/10.1111/phpp.12919
Vancouver
Demircioğlu D, Durmaz EÖ. Luminescence of favipiravir in skin appendages and sclera. A controlled study and literature review. Photodermatology, Photoimmunology & Photomedicine. 2024. doi:10.1111/phpp.12919
BibTeX
@article{Demirciolu2024,
author = {Demircioğlu, Deniz and Durmaz, Emel Öztürk},
title = {Luminescence of favipiravir in skin appendages and sclera. A controlled study and literature review},
journal = {Photodermatology, Photoimmunology & Photomedicine},
year = {2024},
doi = {10.1111/phpp.12919}
}
EUVIMED